TCON - TRACON Pharmaceuticals Inc. (TCON) CEO Charles Theuer on Q3 2020 Results - Earnings Call Transcript

TRACON Pharmaceuticals, Inc. (TCON) Q3 2020 Earnings Conference Call November 10, 2020 4:30 PM ET Company Participants Charles Theuer - President and Chief Executive Officer Scott Brown - Chief Accounting Officer and Head of Finance Conference Call Participants Presentation Operator Good day, ladies and gentlemen, and welcome to TRACON Pharmaceuticals' Third Quarter and 2020 Earnings Conference Call. At this time, all callers are in a listen-only mode. After the speakers' prepared remarks, we will conduct a question-and-answer session, and instructions will be given at that time. During today's call, we will be making certain forward-looking statements, including statements regarding expected timing of clinical trials and results, regulatory activities, future expenses and cash runway and our development plans and strategy. These statements are subject to various risks that are described in our filings made with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the year ended

For further details see:

TRACON Pharmaceuticals, Inc. (TCON) CEO Charles Theuer on Q3 2020 Results - Earnings Call Transcript